Aclarubicin Plus Cyclophosphamide, Vincristine, and Prednisone (CAOP) in Patients With Previously Treated Cutaneous T-cell Lymphoma
Shanghai Jiao Tong University School of Medicine
Shanghai Jiao Tong University School of Medicine
Yale University
Dana-Farber Cancer Institute
Massachusetts General Hospital
Dana-Farber Cancer Institute
Ruijin Hospital
University of Miami
M.D. Anderson Cancer Center
Northwestern University
Fred Hutchinson Cancer Center